Title: Note 2 - Provider Relief Fund (COVID-19) and American Rescue Plan Rural Distribution Assistance Listing Number 93.498
Accounting Policies: Note 1 - Basis of Presentation The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) includes the federal awards of Tidewell Hospice, Inc. (the “Organization”) under programs of the federal government for the year ended September 30, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations, Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) and accounting principles generally accepted in the United States of America. Because the Schedule presents only a select portion of the operations of the Organization, it is not intended to, and does not present, the financial position, changes in net assets, or cash flows of the Organization. Federal funds were received in awards from the U.S. Department of Health and Human Services (“HHS”), including through federal programs established by legislation issued in response to the COVID-19 pandemic.
De Minimis Rate Used: N
Rate Explanation: The Organization has not elected to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance.
For the HHS awards related to the Provider Relief Fund (“PRF”) and the American Rescue Plan Rural Distribution (ARP), HHS has indicated the amounts on the schedule be reported corresponding to reporting requirements of the Health Resources & Services Administrator (“HRSA”) PRF Reporting Portal (the “Portal”). Payments from HHS for PRF and ARP are assigned to ‘Payment Received Periods’ (each, a “Period”) based upon the date each payment from the PRF was received. Each Period has a specified period of availability and timing of reporting requirements. Entities report into the Portal after each Period’s deadline to use the funds (i.e., after the end of the period of availability). The Schedule includes funds received from HHS between July 1, 2021 to June 30, 2022.
Title: Note 3 - Summary of Significant Accounting Policies
Accounting Policies: Note 1 - Basis of Presentation The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) includes the federal awards of Tidewell Hospice, Inc. (the “Organization”) under programs of the federal government for the year ended September 30, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations, Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) and accounting principles generally accepted in the United States of America. Because the Schedule presents only a select portion of the operations of the Organization, it is not intended to, and does not present, the financial position, changes in net assets, or cash flows of the Organization. Federal funds were received in awards from the U.S. Department of Health and Human Services (“HHS”), including through federal programs established by legislation issued in response to the COVID-19 pandemic.
De Minimis Rate Used: N
Rate Explanation: The Organization has not elected to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance.
Expenditures reported on the Schedule are reported using the accrual basis of accounting. The amount of expenditures reported on the Schedule for Assistance Listing Number 93.498 represents expenditures incurred during the period of availability of January 1, 2020 through December 31, 2022. Such expenditures are recognized following, either the cost principles in the Office of Management and Budget and Budget Circular A-122, Cost Principles for Non-Profit Organizations, or the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Title: Note 4 - Indirect Cost Rate
Accounting Policies: Note 1 - Basis of Presentation The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) includes the federal awards of Tidewell Hospice, Inc. (the “Organization”) under programs of the federal government for the year ended September 30, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations, Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) and accounting principles generally accepted in the United States of America. Because the Schedule presents only a select portion of the operations of the Organization, it is not intended to, and does not present, the financial position, changes in net assets, or cash flows of the Organization. Federal funds were received in awards from the U.S. Department of Health and Human Services (“HHS”), including through federal programs established by legislation issued in response to the COVID-19 pandemic.
De Minimis Rate Used: N
Rate Explanation: The Organization has not elected to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance.
The Organization has not elected to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance.
Title: Note 5 - Estimates
Accounting Policies: Note 1 - Basis of Presentation The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) includes the federal awards of Tidewell Hospice, Inc. (the “Organization”) under programs of the federal government for the year ended September 30, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations, Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) and accounting principles generally accepted in the United States of America. Because the Schedule presents only a select portion of the operations of the Organization, it is not intended to, and does not present, the financial position, changes in net assets, or cash flows of the Organization. Federal funds were received in awards from the U.S. Department of Health and Human Services (“HHS”), including through federal programs established by legislation issued in response to the COVID-19 pandemic.
De Minimis Rate Used: N
Rate Explanation: The Organization has not elected to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance.
The preparation of the Schedule in conformity with Uniform Guidance and accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amount during the reporting period. Actual results could differ from those estimates.
Title: Note 6 - Subsequent Events
Accounting Policies: Note 1 - Basis of Presentation The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) includes the federal awards of Tidewell Hospice, Inc. (the “Organization”) under programs of the federal government for the year ended September 30, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations, Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) and accounting principles generally accepted in the United States of America. Because the Schedule presents only a select portion of the operations of the Organization, it is not intended to, and does not present, the financial position, changes in net assets, or cash flows of the Organization. Federal funds were received in awards from the U.S. Department of Health and Human Services (“HHS”), including through federal programs established by legislation issued in response to the COVID-19 pandemic.
De Minimis Rate Used: N
Rate Explanation: The Organization has not elected to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance.
The Schedule and related disclosures include evaluation of events through June 28, 2024, which is the date the Schedule was available to be issued.